Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating activities      
Net income $ 150,548 $ 171,420 $ 132,582
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 160,071 143,394 150,149
Amortization of intangible and other assets and favorable/unfavorable leases 3,899 4,281 4,300
Amortization of long-term prepaid rents 2,625 2,673 2,657
Amortization of debt issue costs 5,476 4,792 4,744
Amortization of deferred revenues, deferred lease incentives and other (11,712) (9,343) (9,629)
Amortization of bond discount 482 933 853
Amortization of accumulated other comprehensive loss related to terminated interest rate swap agreement   2,470 4,236
Fair value change in interest rate swap agreements not designated as hedges   (808) (1,130)
Impairment of long-lived assets 3,794 3,031 7,033
Share based awards compensation expense 16,886 15,070 9,692
(Gain) loss on sale of assets and other (3,845) 12,168 8,792
Loss on marketable securities - RealD     12,610
Write-off of unamortized debt issue costs, debt discount and accumulated other comprehensive loss related to early retirement of debt 15,688   4,945
Deferred lease expenses 5,701 4,104 4,155
Deferred income tax expenses (37,790) 5,280 21,676
Equity in earnings (22,682) (13,109) (5,651)
Interest paid on redemption of senior notes (8,054)    
Distributions from equity investees 13,658 7,470 7,125
Changes in other assets and liabilities and other 14,921 41,379 32,062
Net cash provided by operating activities 309,666 395,205 391,201
Investing activities      
Additions to theatre properties and equipment (259,670) (220,727) (184,819)
Proceeds from disposition of Mexico theatres 34,271 1,976 6,230
Investment in joint ventures and other (6,222) (1,480) (1,520)
Net cash used for investing activities (364,701) (234,311) (247,067)
Financing Activities      
Proceeds from stock option exercises 57 459 444
Payroll taxes paid as a result of noncash stock option exercises and restricted stock withholdings (3,464) (3,263) (494)
Dividends paid to stockholders (106,045) (96,367) (95,838)
Proceeds from issuance of notes 530,000 400,000 200,000
Other short term borrowings 1,473    
Proceeds from amended senior secured credit facility   700,000  
Repayment of former senior secured credit facility   (898,955)  
Redemption of senior notes (461,946)    
Repayments of other long-term debt (9,339) (9,711) (166,898)
Payment of debt issue costs (9,328) (18,453) (4,539)
Payments on capital leases (12,015) (9,451) (7,526)
Purchases of non-controlling interests (5,621)   (1,443)
Other 44 (835) (2,120)
Net cash provided by (used for) financing activities (76,184) 63,424 (78,414)
Effect of exchange rates on cash and cash equivalents (11,516) (3,062) (9,309)
Increase (decrease) in cash and cash equivalents (142,735) 221,256 56,411
Cash and cash equivalents:      
Beginning of period 742,664 521,408 464,997
End of period 599,929 742,664 521,408
United States
      
Investing activities      
Acquisition of theatres in the U.S. and theatres in Argentina (259,247) (14,080)  
Argentina
      
Investing activities      
Acquisition of theatres in the U.S. and theatres in Argentina     (66,958)
Mexico
      
Investing activities      
Proceeds from disposition of Mexico theatres $ 126,167